Profile of Reactive Estrogen Species in Women with EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC)

被引：0
|
作者：
Bodor, J. N. [1 ]
Krzizike, D. D. [1 ]
Vanderveer, L. [1 ]
Eidbo, S. [1 ]
Zawislak, C. L. [1 ]
Ross, E. A. [1 ]
Andrews, A. J. [2 ]
Edelman, M. J. [1 ]
Treat, J. [1 ]
Clapper, M. L. [1 ]
机构：
[1] Fox Chase Canc Ctr, Philadelphia, PA USA
[2] Univ North Carolina Wilmington, Wilmington, NC USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
EGFR; Reactive Catechols; Estrogen; Metabolism;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OA13.04
引用
收藏
页码：S75 / S75
页数：1
相关论文
共 50 条
  • [21] Estrogen and its signaling pathway in non-small cell lung cancer(NSCLC)
    Ruitong Xu
    Journal of Nanjing Medical University, 2009, 23 (04) : 217 - 223
  • [22] Treatment patterns and survival analysis in patients with unresectable stage III EGFR-mutated non-small cell lung cancer
    Liang, Huan-Wei
    Liu, Yang
    Pan, Xin-Bin
    AGING-US, 2024, 16 (01): : 857 - 871
  • [23] Survival Disparities in Black Patients With EGFR-mutated Non-small-cell Lung Cancer
    Cheng, Haiying
    Hosgood, H. Dean
    Deng, Lei
    Ye, Kenny
    Su, Christopher
    Sharma, Janaki
    Yang, Yuanquan
    Halmos, Balazs
    Perez-Soler, Roman
    CLINICAL LUNG CANCER, 2020, 21 (02) : 177 - 185
  • [24] The significance of co-mutations in EGFR-mutated non-small cell lung cancer: Optimizing the efficacy of targeted therapies?
    Pezzuto, Federica
    Hofman, Veronique
    Bontoux, Christophe
    Fortarezza, Francesco
    Lunardi, Francesca
    Calabrese, Fiorella
    Hofman, Paul
    LUNG CANCER, 2023, 181
  • [25] Osimertinib beyond Progression in Patients with EGFR Mutated Non-small Cell Lung Cancer (NSCLC) Receiving Frontline Osimertinib
    Benyounes, A.
    Cohen, A.
    Rossi, S. Diamond
    Cannon, T.
    Yacur, M.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S657 - S657
  • [26] Combined Inhibition of EGFR and VEGF Pathways in Patients with EGFR-Mutated Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
    Peravali, Monica
    Wang, Haijun
    Kim, Chul
    Veytsman, Irina
    CURRENT ONCOLOGY REPORTS, 2020, 22 (12)
  • [27] Combined Inhibition of EGFR and VEGF Pathways in Patients with EGFR-Mutated Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
    Monica Peravali
    Haijun Wang
    Chul Kim
    Irina Veytsman
    Current Oncology Reports, 2020, 22
  • [28] Prognostic role of circulating tumor cells in patients with EGFR-mutated or ALK-rearranged non-small cell lung cancer
    Tong, Bing
    Xu, Yan
    Zhao, Jing
    Chen, Minjiang
    Zhong, Wei
    Xing, Jia
    Wang, Mengzhao
    THORACIC CANCER, 2018, 9 (05) : 640 - 645
  • [29] Cost-effectiveness analysis of osimertinib plus chemotherapy for patients with EGFR-mutated advanced non-small cell lung cancer
    Tian, Wentao
    Niu, Lishui
    Zhou, Rongrong
    Wang, Ziqi
    Ning, Jiaoyang
    Lu, Ruoyu
    Shi, Yin
    Tan, Zhaohua
    CANCER MEDICINE, 2024, 13 (16):
  • [30] Osimertinib in Relapsed EGFR-Mutated, T790M-Negative Non-Small Cell Lung Cancer (NSCLC) Patients: Results from the TREM-Study
    Eide, I. J.
    Helland, A.
    Borrisova, S.
    Ekman, S.
    Cicenas, S.
    Koivunen, J.
    Gronberg, B. H.
    Brustugun, O. T.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2140 - S2141
12345